Back
Ares Management 10K Form
Buy
70
ARES
Ares Management
Last Price:
$168.60
Seasonality Move:
11.57%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2023-11-06 | 10Q | ARES/Ares Management Quarterly |
2023-08-03 | 10Q | ARES/Ares Management Quarterly |
2023-05-08 | 10Q | ARES/Ares Management Quarterly |
2022-11-07 | 10Q | ARES/Ares Management Quarterly |
2022-08-05 | 10Q | ARES/Ares Management Quarterly |
2022-05-09 | 10Q | ARES/Ares Management Quarterly |
Receive ARES News And Ratings
See the #1 stock for the next 7 days that we like better than ARES
ARES Financial Statistics
Sales & Book Value
Annual Sales: | $3.9B |
---|---|
Cash Flow: | $2B |
Price / Cash Flow: | 8.63 |
Annual Sales: | $13.71 |
Price / Book: | 12.41 |
Profitability
EPS (TTM): | 1.70000 |
---|---|
Net Income (TTM): | $437.9M |
Gross Margin: | $2.2B |
Return on Equity: | 7.29% |
Return on Assets: | 1.75% |
Ares Management Earnings Forecast
Key Ares Management Financial Ratios
-
The Gross Profit Margin over the past 14 years for ARES is 55.42%.
-
The Selling, General & Administrative Expenses for ARES have been equal to 30.53% of Gross Profit Margin.
-
The Research & Development expenses have been 0.00% of Revenue.
-
The Interest Expense is 210.96% of Operating Income.
-
The Net Earning history of ARES is 11.94% of Total Revenues.
-
Per Share Earnings over the last 14 years have been positive in 5 years.
Ares Management Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NYSE |
---|---|
Industry: | Capital Markets |
Sector: | Financials |
Current Symbol: | ARES |
CUSIP: | 03990B |
Website: | aresmgmt.com |
Debt
Debt-to-Equity Ratio: | 2.84 |
---|---|
Current Ratio: | 0.58 |
Quick Ratio: | 0.58 |
Price-to-Earnings
Trailing P/E Ratio: | 83.41 |
---|---|
Forward P/E Ratio: | 26.27 |
ARES Technical Analysis vs Fundamental Analysis
Buy
70
Ares Management (ARES)
is a Buy
Is Ares Management a Buy or a Sell?
-
Ares Management stock is rated a BuyThe current Ares Management [ARES] share price is $170.15. The Score for ARES is 70, which is 40% above its historic median score of 50, and infers lower risk than normal.